跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARANESP darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard - TGA Drug Approval Details
Approvals
/
TGA
/
ARANESP darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard
Approved
STANDARD
ARANESP darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
1bbb4318c816ac92
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1bbb4318c816ac92
Product Name
ARANESP darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard
Artg Id
166092
Artg Name
ARANESP darbepoetin alfa (rch) 30 microgram/0.3mL injection syringe with automatic needle guard
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2010-06-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-06895-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-04194-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
1bbb4318c816ac92
Type
Standard
Back to TGA Approvals